The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis

Molecular and Cellular Biology

Volumn 21, Issue 16, 2001, Pages 5678-5687

  Luo, R T ^a   Lavau, C ^a   Du, C ^a   Simone, F ^a   Polak, P E ^a   Kawamata, S ^a   Thirman, M J ^a  

^a MC2115 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR; GENE PRODUCT; PROTEIN MLL ELL; RNA POLYMERASE II; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CELL IMMORTALIZATION; CELL TRANSPLANTATION; CONTROLLED STUDY; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; LEUKEMOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION; TRANSACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; LEUKEMIA; MICE; MOLECULAR SEQUENCE DATA; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; PEPTIDE ELONGATION FACTORS; PROTO-ONCOGENES; SEQUENCE ALIGNMENT; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ELONGATION FACTORS;

EID: 0034928761     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.16.5678-5687.2001     Document Type: Article

References (33)

1. Elongin (SIII): A multisubunit regulator of elongation by RNA polymerase II
2. The HRX proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures
3. Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations
4. An Ml1-Af9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: A method to create fusion oncogenes
5. MLL rearrangements in haematological malignancies: Lessons from clinical and biological studies
6. A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL
7. Tumorigenesis in mice with a fusion of the leukaemia oncogene Ml1 and the bacterial lacZ gene
8. Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product
9. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene
10. Fidelity of RNA polymerase II transcription controlled by elongation factor TFIIS
11. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL
12. Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia
13. Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice
14. LAF-4 encodes a lymphoid nuclear protein with transactivation potential that is homologous to AF-4, the gene fused to MLL in t(4;11) leukemias
15. Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs
16. The chromatin-specific transcription elongation factor FACT comprises human SPT16 and SSRP1 proteins
17. Domains with transcriptional regulatory activity within the ALL1 and AF4 proteins involved in acute leukemia
18. Mechanism and regulation of transcriptional elongation by RNA polymerase II
19. The localization of the HRX/ALL1 protein to specific nuclear subdomains is altered by fusion with its eps15 translocation partner
20. ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells
21. An RNA polymerase II elongation factor encoded by the human ELL gene
22. Structure and function of RNA polymerase II elongation factor ELL. Identification of two overlapping ELL functional domains that govern its interaction with polymerase and the ternary elongation complex
23. ELL2, a new member of an ELL family of RNA polymerase II elongation factors
24. EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein
25. The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX
26. AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23)
27. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations
28. Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia
29. Developmental analysis and subcellular localization of the murine homologue of ELL
30. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias
31. Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro
32. Nuclear punctate distribution of ALL-1 is conferred by distinct elements at the N terminus of the protein
33. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias